PRESS & NEWS

For Press or Analyst Inquiries, Please contact press@tact.ai

Press and News [age hero image
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
2021
September 20, 2021

Life Sciences and Healthcare Industry Leaders Invest in Tact.ai to Deliver Next Generation Customer Engagement

AI Company adds $33 million in new equity financing from Novartis (dRx Capital), Eli Lilly and Company, McKesson Ventures and existing investors to help the life sciences industry accelerate the future of working with customers.

2021
April 8, 2021

CB Insights reveals 2021 cohort of 100 most-promising AI companies

One way to gauge the deployment of artificial intelligence in the marketplace is to track CB Insights' top 100 most-promising private AI companies to watch. The firm released its annual list this week, culled from over 6,000 companies. "This ye...

2021
April 7, 2021

AI 100: The Artificial Intelligence Startups Redefining Industries

The AI 100 is CB Insights' annual list of the 100 most promising private AI companies in the world. This year’s winners are working on solutions including AI transparency, climate risk, virus modeling, and more. CB Insights has unveiled the win...

2021
April 7, 2021

Tact.ai Named to the 2021 CB Insights AI 100 List of Most Innovative Artificial Intelligence Startups

Tact honored for achievements in Sales and CRM. CB Insights today named Tact.ai to the fifth annual AI 100 ranking, showcasing the 100 most promising private artificial intelligence companies in the world. Tact.ai is one of only five companies se...

2021
March 16, 2021

Tact.ai and BASE life science Partner to Help Field Teams Digitize and Accelerate New Models of HCP Engagement

Tact.ai, the human-friendly CRM company, and BASE life science, a specialist in sales and marketing innovation for pharmaceutical and life sciences companies, announced a new partnership designed to help life science brands improve engagement wit...

2021
March 16, 2021

Tact.ai and BASE life science Partner to Help Field Teams Digitize and Accelerate New Models of HCP Engagement

Tact.ai, the human-friendly CRM company, and BASE life science, a specialist in sales and marketing innovation for pharmaceutical and life sciences companies, announced a new partnership designed to help life science brands improve engagement wi...

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
2022
October 7, 2022

Tact.ai accueille deux nouveaux cadres de l'industrie pharmaceutique en tant que conseillers du conseil d'administration afin d'accélérer l'innovation dans l'engagement client des sciences de la vie

Tact.ai, la société d'engagement client pour les sciences de la vie, a annoncé la nomination de deux nouveaux conseillers du conseil d'administration issus de l'industrie pharmaceutique : Giuseppe Firenze, responsable de l'information commerciale mondiale chez Eli Lilly and Company, et Desmond Creary, responsable de l'engagement client chez Novartis US. Giuseppe et Desmond joueront un rôle clé dans le développement des capacités avancées de la plateforme pour permettre de fournir plus rapidemen

2022
October 7, 2022

Tact.ai begrüßt zwei neue Executives aus dem Pharmabereich als Board Advisors zur Beschleunigung der Innovation im Kundenengagement von Life Sciences

Tact.ai, das Kundenengagement-Unternehmen für Life Sciences, hat die Ernennung von zwei neuen Board Advisors aus der Pharmaindustrie bekanntgegeben: Giuseppe Firenze, Global Commercial Information Officer von Eli Lilly and Company und Desmond Creary, Chief Customer Engagement Officer für Novartis US. Giuseppe Firenze und Desmond Creary werden eine wichtige Rolle bei der Entwicklung der erweiterten Funktionen der Plattform übernehmen, um möglichst viele Patienten schneller mit innovativen Medikam

2022
October 6, 2022

Tact.ai Welcomes Two New Pharma Executives as Board Advisors to Accelerate Innovation in Life Sciences Customer Engagement

Tact.ai welcomes two new pharma executives as board advisors to accelerate innovation in life sciences customer engagement. Giuseppe Firenze, Global Commercial Information Officer of Eli Lilly and Company, and Desmond Creary, Chief Customer Engagement Officer for Novartis US. Giuseppe and Desmond will play key roles in the development of the platform’s advanced capabilities to help deliver innovative medicines to more patients faster.

2022
June 30, 2022

Tact.ai’s New Customer Engagement Capabilities Help Pharma Close the Access Gap and Improve Personalized Connections with HCPs

Tact.ai, the customer engagement company for life sciences,announced today a set of new capabilities that improve customer access for thefield. The new capabilities help teams appear in customer inboxes morefrequently, and work where the HCPs want to work – like Microsoft Teams forremote engagement – in a compliant way whilst providing them the data &content they need to deliver personalized journeys across all channels.

2022
May 4, 2022

Tact.ai Establishes Customer Advisory Board, Names Former Novartis Pharma Global CIO and SVP Andreas Müller as Advisor

Tact.ai, the customer engagement company for life sciences, announced today that former Novartis Pharma Global CIO and SVP, Andreas Müller, has joined the company as an Advisor. His role will focus on working with commercial and medical leaders to accelerate successful hybrid customer engagement that support new and more agile go-to-market models.

2022
March 29, 2022

Hikma Ventures invests in Tact.ai, an AI-powered customer engagement platform for life sciences companies

Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces that its venture capital arm, Hikma Ventures has invested in Tact.ai, the customer engagement company for life sciences. Tact.ai helps pharmaceutical companies work more effectively with health care professionals (HCPs) to deliver innovative medicines to patients faster. The investment is the fourth Life Sciences industry investment in the past six months for Tact.ai, following its $33 million USD fundraise...